Back to Companies
Telix Pharmaceuticals Ltd
TLXOTCCIK: 0002007191
Over the 12 most recent insider filings, Telix Pharmaceuticals Ltd (TLX) has seen activity from 10 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $1.0M bought versus $0 sold, a net purchase of $1.0M. Behrenbruch Christian (MD & Group CEO, Director) is the most active by dollar volume, and the single largest transaction was $996.7K by Behrenbruch Christian. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.0M
Purchases
$1.0M
Sales
$0
Unique Insiders
10
Recent Insider Trades
12 loaded
| Sep 14 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Buy | $20.0K |
| May 18 | TLX Telix Pharmaceuticals Ltd | Rivas Maria | Director | Other | $0 |
| May 18 | TLX Telix Pharmaceuticals Ltd | Jellison William R | Director | Other | $0 |
| May 18 | TLX Telix Pharmaceuticals Ltd | GILL DAVID N | Director | Other | $0 |
| May 6 | TLX Telix Pharmaceuticals Ltd | Behrenbruch Christian | MD & Group CEO, Director | Buy | $996.7K |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Exercise | $0 |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Cade David Norman | Group Chief Medical Officer | Other | $0 |
| Mar 18 | TLX Telix Pharmaceuticals Ltd | Skinner Jann Elizabeth | Director | Other | $0 |
| Mar 18 | TLX Telix Pharmaceuticals Ltd | McDonald Marie Elizabeth | Director | Other | $0 |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Patti Darren Joel | Group Chief Operating Officer | Other | $0 |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Nelson Mark Alexander | Director | Other | $0 |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Other | $0 |
12 filings